<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE book-part-wrapper PUBLIC "-//NLM//DTD BITS Book Interchange DTD v2.0 20151225//EN" "http://jats.nlm.nih.gov/extensions/bits/2.0/BITS-book2.dtd">
<book-part-wrapper id="article-17775" content-type="chapter" dtd-version="2.0">
  <book-meta>
    <book-id book-id-type="pmcid">statpearls</book-id>
    <book-title-group>
      <book-title>StatPearls</book-title>
    </book-title-group>
    <pub-date publication-format="electronic" date-type="pubr">
      <month>01</month>
      <year>2024</year>
    </pub-date>
    <publisher>
      <publisher-name>StatPearls Publishing</publisher-name>
      <publisher-loc>Treasure Island (FL)</publisher-loc>
    </publisher>
    <permissions>
      <copyright-statement>Copyright &#x000a9; 2024, StatPearls Publishing LLC</copyright-statement>
      <license xmlns:xlink="http://www.w3.org/1999/xlink" license-type="open-access" xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/">
        <license-p>
This book is distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0)
(<ext-link xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/" ext-link-type="uri">
http://creativecommons.org/licenses/by-nc-nd/4.0/
</ext-link>), which permits others to distribute the work, provided that the article is not altered or used commercially. You are not required to obtain permission to distribute this article, provided that you credit the author and journal.
</license-p>
      </license>
    </permissions>
    <custom-meta-group>
      <custom-meta>
        <meta-name>books-source-type</meta-name>
        <meta-value>Database</meta-value>
      </custom-meta>
    </custom-meta-group>
    <notes notes-type="disclaimer">
      <p>The intent of StatPearls review books and articles is to identify knowledge deficits and assist you in the learning process. Review books and articles are not intended to be a source of the knowledge base of medicine. The authors and editors do not warrant the information is complete or accurate. The reader is encouraged to verify content and questions in several references. All drug indications and dosages should be verified before administration.</p>
      <p>The authors and editors would like to extend special thanks to Erin Hughes and Gerson Rubio for their editorial support.</p>
    </notes>
  </book-meta>
  <book-part book-part-type="chapter">
    <book-part-meta>
      <title-group>
        <title>Apocrine Hidrocystoma</title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Hafsi</surname>
            <given-names>Wissem</given-names>
          </name>
          <aff>Faculty of Medicine of Tunis, Tunisia</aff>
        </contrib>
      </contrib-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Syed</surname>
            <given-names>Hasnain A.</given-names>
          </name>
          <aff>Sheikh Zayed Hospital, Lahore</aff>
        </contrib>
      </contrib-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Shah</surname>
            <given-names>Farhan</given-names>
          </name>
          <aff>LewisGale Medical Center</aff>
        </contrib>
      </contrib-group>
      <author-notes>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Wissem Hafsi declares no relevant financial relationships with ineligible companies.</p>
        </fn>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Hasnain Syed declares no relevant financial relationships with ineligible companies.</p>
        </fn>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Farhan Shah declares no relevant financial relationships with ineligible companies.</p>
        </fn>
      </author-notes>
      <pub-history>
        <date date-type="updated">
          <day>13</day>
          <month>4</month>
          <year>2024</year>
        </date>
      </pub-history>
    </book-part-meta>
    <body>
      <sec id="article-17775.s1" sec-type="Continuing Education Activity">
        <title>Continuing Education Activity</title>
        <p>Apocrine hidrocystoma is a rare, benign cystic tumor originating from the&#x000a0;secretory part of the apocrine sweat glands.&#x000a0;The tumor typically presents as a solitary, asymptomatic papule or nodule and is commonly found on the head and neck, although it may occasionally appear in other areas.&#x000a0;The exact cause and pathogenesis of this condition remain unknown.&#x000a0;Currently, apocrine hidrocystoma is regarded as a cystic proliferation of apocrine glands rather than a simple retention cyst.</p>
        <p>Although apocrine hidrocystoma is often a solitary growth, multiple apocrine hidrocystomas can also occur in 2 rare ectodermal dysplasias&#x02014;a specific form of Goltz-Gorlin syndrome and Schopf-Schultz-Passarge syndrome. In addition, a unique presentation combining multiple apocrine hidrocystomas with additional clinical findings,&#x000a0;including bilateral keratoconus, esophageal papillomatosis, and hiatus hernia, has been documented&#x000a0;in a particular form. Histological examination typically confirms the diagnosis, while dermoscopic findings may reveal various patterns and structures. Given the benign nature of the lesion, surgical excision with narrow margins is the primary treatment. This activity outlines the epidemiology, genetics, and clinical presentation of apocrine hidrocystoma, emphasizing its rarity, diagnostic approaches, and management strategies. This activity provides clinicians with the necessary knowledge and tools to diagnose and treat&#x000a0;this relatively common yet complex condition and enhance patient care and outcomes.</p>
        <p>
<bold>Objectives:</bold>
<list list-type="bullet"><list-item><p>Identify the clinical characteristics and typical presentation of apocrine hidrocystoma.</p></list-item><list-item><p>Implement appropriate diagnostic procedures, such as histological examination, to confirm apocrine hidrocystoma diagnosis.</p></list-item><list-item><p>Select the most appropriate treatment modality for apocrine hidrocystoma based on lesion characteristics, patient preferences, and potential comorbidities.</p></list-item><list-item><p>Collaborate with dermatologists and other specialists to ensure accurate diagnosis and optimal management of apocrine hidrocystoma, especially in complex cases.</p></list-item></list>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=17775&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=17775">Access free multiple choice questions on this topic.</ext-link>
</p>
      </sec>
      <sec id="article-17775.s2" sec-type="pubmed-excerpt">
        <title>Introduction</title>
        <p>Apocrine hidrocystoma is a rare, benign cystic tumor originating from the&#x000a0;secretory part of the apocrine sweat glands.&#x000a0;The tumor typically presents as a solitary, asymptomatic papule or nodule and is commonly found on the head and neck. Apocrine hidrocystomas usually range from 3 to 15 mm in size and may appear translucent, often exhibiting noted mobility.&#x000a0;Occasionally,&#x000a0;the benign tumor may present in other areas.<xref ref-type="bibr" rid="article-17775.r1">[1]</xref>&#x000a0;</p>
        <p>Although apocrine hidrocystoma typically presents as a solitary growth, rare multiple forms can also occur, potentially serving as important markers for certain inherited diseases or ectodermal dysplasia, such as a particular form of Goltz-Gorlin syndrome and Schopf-Schultz-Passarge syndrome.&#x000a0;Apocrine hidrocystoma is typically diagnosed through histological examination, allowing clinicians to confirm the diagnosis.<xref ref-type="bibr" rid="article-17775.r2">[2]</xref></p>
      </sec>
      <sec id="article-17775.s3" sec-type="Etiology">
        <title>Etiology</title>
        <p>Apocrine hidrocystomas arise from an inappropriate tumorous growth of apocrine sweat glands.<xref ref-type="bibr" rid="article-17775.r2">[2]</xref>&#x000a0;Although the exact etiological factors of this condition remain unknown, sun exposure is considered a potential risk factor and is not associated with familial incidence.<xref ref-type="bibr" rid="article-17775.r1">[1]</xref></p>
      </sec>
      <sec id="article-17775.s4" sec-type="Epidemiology">
        <title>Epidemiology</title>
        <p>Apocrine hidrocystoma primarily affects adults aged 30 to 70, with rare occurrences during childhood or adolescence.<xref ref-type="bibr" rid="article-17775.r3">[3]</xref>&#x000a0;Solitary apocrine hidrocystomas occur equally in both men and women without any apparent ethnic or geographic predilection. Multiple forms of apocrine hidrocystomas are rare in the general population.&#x000a0;</p>
      </sec>
      <sec id="article-17775.s5" sec-type="Pathophysiology">
        <title>Pathophysiology</title>
        <p>Although the pathogenesis of apocrine hidrocystoma is unclear, it involves the tumor originating from the secretory part of apocrine sweat glands. Apocrine hidrocystoma&#x000a0;is&#x000a0;currently considered a cystic proliferation of apocrine glands rather than a simple retention cyst.&#x000a0;Although apocrine hidrocystoma typically presents as a solitary growth, rare multiple forms&#x000a0;have been described in&#x000a0;2 rare ectodermal dysplasias,&#x000a0;including&#x000a0;a particular form of Goltz-Gorlin and Schopf-Schultz-Passarge syndromes.<xref ref-type="bibr" rid="article-17775.r4">[4]</xref>&#x000a0;</p>
        <p>Goltz-Gorlin syndrome, also known as focal dermal hypoplasia, is an X-linked dominant disease characterized by linear skin atrophy, microcephaly, microphthalmia, midfacial hypoplasia, malformation of the ears,&#x000a0;intellectual disability, and skeletal abnormalities.<xref ref-type="bibr" rid="article-17775.r5">[5]</xref><xref ref-type="bibr" rid="article-17775.r6">[6]</xref>&#x000a0;Some additional clinical findings have been described in a particular form, featuring a combination of multiple apocrine hidrocystomas, bilateral keratoconus, esophageal papillomatosis, and hiatus hernia.</p>
        <p>Schopf-Schultz-Passarge syndrome is an autosomal recessive condition characterized by multiple eyelid apocrine hidrocystomas accompanied by hypotrichosis, hypodontia, palmar and plantar hyperkeratosis, and nail fragility.<xref ref-type="bibr" rid="article-17775.r7">[7]</xref><xref ref-type="bibr" rid="article-17775.r8">[8]</xref></p>
      </sec>
      <sec id="article-17775.s6" sec-type="Histopathology">
        <title>Histopathology</title>
        <p>Apocrine hidrocystoma typically features an inner cyst wall lined by luminal columnar cells indicating apocrine secretion alongside a peripheral layer of flattened myoepithelial cells, similarly seen in the secretory portion of the normal apocrine gland. These cysts can present as either unilocular or multilocular. The epithelium consists of a single or double layer of cuboidal-columnar cells located superiorly to an outer myoepithelial cell layer. The cystic space is lined by a bilaminar epithelium, with columnar cells on the inner surface displaying eosinophilic characteristics and prominent luminal blebbing, often referred to as apocrine snouts. Periodic acid-Schiff (PAS)-positive granules are also observed along with lipofuscin granules. In addition, apocrine hidrocystomas exhibit papillary projections and vascular connective tissue covered by the secretory epithelium.<xref ref-type="bibr" rid="article-17775.r9">[9]</xref></p>
      </sec>
      <sec id="article-17775.s7" sec-type="History and Physical">
        <title>History and Physical</title>
        <p>Apocrine hidrocystoma is predominantly solitary, although clinicians have documented multiple lesions. Typically intradermal, apocrine hidrocystoma manifests as a moderately firm, dome-shaped, translucent cystic nodule, often presenting with a blue, bluish-black, grayish, or purple hue (see <bold>Image.</bold> Apocrine Hidrocystoma). Sizes range from 3 to 15 mm in diameter, with rare giant variants measuring up to 7 cm. Apocrine hidrocystomas are more frequently pigmented than eccrine hidrocystomas. Furthermore, apocrine hidrocystomas do not change or become symptomatic even in hot weather conditions.<xref ref-type="bibr" rid="article-17775.r9">[9]</xref></p>
        <p>Apocrine hidrocystoma is commonly found on the head, face, and neck, possibly because apocrine glands are frequent in sun-exposed areas.<xref ref-type="bibr" rid="article-17775.r10">[10]</xref>&#x000a0;The main differential diagnosis of the rare cases of multiple apocrine hidrocystomas&#x000a0;is multiple eccrine hidrocystomas, which are typically smaller, with diameters ranging from 1 to 6 mm. Eccrine hidrocystomas tend to exhibit a brown or bluish color, which is clearer compared to apocrine hidrocystomas.&#x000a0;Furthermore, another important differential fact of eccrine hidrocystomas is that they tend to increase in size and number in warmer summer environments and may disappear in cooler weather conditions.<xref ref-type="bibr" rid="article-17775.r11">[11]</xref></p>
      </sec>
      <sec id="article-17775.s8" sec-type="Evaluation">
        <title>Evaluation</title>
        <p>Dermoscopic findings reveal a homogeneous pale gray or bluish pattern, along with whitish cotton wool-like structures, linear vessels, and nonconstant focal brownish-orange areas.<xref ref-type="bibr" rid="article-17775.r12">[12]</xref>&#x000a0;The grayish color is likely attributed to sialomucin, inducing a diffraction effect similar to Kaposi sarcoma. The whitish structures result from the reflection of connective tissue, whereas the brownish-orange structures may be explicated by the presence of clear cells containing significant amounts of glycogen. The dermoscopic sign of peripheral linear vessels corresponds to dilated vessels in the papillary dermis.</p>
        <p>The primary focus of dermoscopy is to ensure the absence of dermoscopic features indicative of a malignant tumor&#x000a0;that may have a similar clinical presentation, mainly amelanotic melanoma and basal cell carcinoma.<xref ref-type="bibr" rid="article-17775.r13">[13]</xref><xref ref-type="bibr" rid="article-17775.r14">[14]</xref><xref ref-type="bibr" rid="article-17775.r15">[15]</xref><xref ref-type="bibr" rid="article-17775.r16">[16]</xref>&#x000a0;Although apocrine hidrocystomas are clinically suspected, their definitive diagnosis relies on histological examination, where a tissue sample is examined under a microscope.</p>
      </sec>
      <sec id="article-17775.s9" sec-type="Treatment / Management">
        <title>Treatment / Management</title>
        <p>The primary treatment for apocrine hidrocystoma is surgical excision with narrow margins, as the lesion is benign. This approach is crucial for the definitive diagnosis by the treating clinician. While needle puncture is an alternative therapy, this form of treatment often leads to local recurrence.<xref ref-type="bibr" rid="article-17775.r11">[11]</xref>&#x000a0;Cyst puncture followed by hypertonic glucose sclerotherapy has shown successful outcomes in treating eyelid apocrine hidrocystoma.<xref ref-type="bibr" rid="article-17775.r17">[17]</xref>&#x000a0;Trichloroacetic acid injection followed by aspiration after cyst puncture offers a nonsurgical alternative. Additionally, botulinum toxin A has demonstrated effectiveness in some cases.<xref ref-type="bibr" rid="article-17775.r18">[18]</xref></p>
      </sec>
      <sec id="article-17775.s10" sec-type="Differential Diagnosis">
        <title>Differential Diagnosis</title>
        <p>Apocrine hidrocystomas closely resemble several conditions and require differentiation from basal cell carcinoma, blue nevi, cutaneous melanoma, eccrine cystadenoma, follicular cyst, milia, and syringoma.</p>
      </sec>
      <sec id="article-17775.s11" sec-type="Prognosis">
        <title>Prognosis</title>
        <p>Apocrine hidrocystomas typically grow slowly and persist indefinitely once they reach their full size. Proper removal usually prevents their recurrence, as they are entirely benign. Although cysts may cause mild irritation in patients, the symptoms are generally mild or absent, and they rarely affect vision.&#x000a0;The prognosis for apocrine hidrocystomas is generally favorable, with surgical excision serving as the curative treatment in most cases. However, individual factors such as location, size, and patient health should be considered, and regular follow-up is crucial to monitor for any potential recurrence.<xref ref-type="bibr" rid="article-17775.r19">[19]</xref></p>
      </sec>
      <sec id="article-17775.s12" sec-type="Complications">
        <title>Complications</title>
        <p>Apocrine hidrocystomas are typically benign lesions; however, like any medical condition, they are associated with certain complications, especially if they are left untreated or if they are presented unusually.</p>
        <p>A few possible complications include:</p>
        <list list-type="bullet">
          <list-item>
            <p>Superadded or secondary infection: Although rare, apocrine hidrocystomas may become infected, especially if the lesion is traumatized or concurrent inflammation is present. Infected lesions present with increased pain, redness, swelling, warmth, and pus discharge. In such cases, antibiotic treatment or surgical drainage may be necessary.</p>
          </list-item>
          <list-item>
            <p>Cosmetic concerns: Apocrine hidrocystomas usually occur on the face, particularly the eyelids, and depending on their size and location, can lead to cosmetic disfigurement or distress. Larger or multiple cysts may further impact facial aesthetics and negatively impact the patient's self-esteem.</p>
          </list-item>
          <list-item>
            <p>Functional impairment: In some cases, apocrine hidrocystomas can grow large enough to interfere with normal eyelid function, leading to symptoms such as mechanical ptosis, ectropion, or entropion. Correcting functional impairment may require surgical intervention.</p>
          </list-item>
          <list-item>
            <p>Recurrence: Although uncommon, apocrine hidrocystomas may rarely recur following treatment, especially if the cyst is incompletely excised. Addressing recurrence may require additional interventions and long-term close follow-up.</p>
          </list-item>
          <list-item>
            <p>Malignant transformation: Although infrequent, isolated cases have reported apocrine hidrocystomas undergoing malignant transformation into a type of skin cancer known as hidradenocarcinoma. This complication underscores the importance of accurate diagnosis, appropriate management, and long-term monitoring of these lesions.</p>
          </list-item>
          <list-item>
            <p>Psychological impact: Chronic skin conditions, especially those affecting the face, may have a significant psychological impact on patients, leading to feelings of self-consciousness, anxiety, or depression. Addressing the psychosocial aspects of coping with apocrine hidrocystomas is an important aspect of comprehensive care.</p>
          </list-item>
        </list>
        <p>Although typically benign, apocrine hidrocystomas can lead to complications, including infection, cosmetic concerns, functional impairment, chronic discomfort, recurrence, and, in rare instances, malignant transformation. Effective management strategies should be personalized to address both the physical and psychological aspects of the condition.&#x000a0;</p>
      </sec>
      <sec id="article-17775.s13" sec-type="Deterrence and Patient Education">
        <title>Deterrence and Patient Education</title>
        <p>Patients are advised to consult their clinician upon noticing a single raised skin lesion or multiple entities. This proactive step aids in evaluating the possibility of malignancies and determining appropriate measures to prevent further growth.</p>
      </sec>
      <sec id="article-17775.s14" sec-type="Pearls and Other Issues">
        <title>Pearls and Other Issues</title>
        <p>Apocrine hidrocystoma&#x000a0;is a benign cystic lesion that commonly manifests on the face. While clinical features may raise suspicion, the formal diagnosis relies on histological examination. Management of apocrine hidrocystoma mainly involves surgical excision; however, alternatives such as electrodesiccation, carbon dioxide laser vaporization, botulinum toxin A, and trichloroacetic acid are also viable, akin to the treatment of eccrine hidrocystomas.</p>
        <p>Lesions typically grow gradually and do not spontaneously resolve after reaching full size. Recurrence following surgical excision is rare. Although cysts may cause&#x000a0;aesthetic concerns and psychological distress in patients, they are generally asymptomatic. Notably, no cases of malignant transformation of apocrine hidrocystoma have been reported to date.</p>
      </sec>
      <sec id="article-17775.s15" sec-type="Enhancing Healthcare Team Outcomes ">
        <title>Enhancing Healthcare Team Outcomes </title>
        <p>Apocrine hidrocystoma&#x000a0;is a benign cystic lesion that typically occurs on&#x000a0;the face and is a rare lesion that primary care&#x000a0;clinicians may encounter. Referral to a dermatologist is strongly advised for further evaluation. Although the diagnosis may be suspected based on clinical characteristics,&#x000a0;confirmation&#x000a0;is based on&#x000a0;histological examination. Management of apocrine hidrocystoma mainly involves surgical excision. However, alternative treatments such as electrodesiccation, carbon dioxide laser vaporization, botulinum toxin A, and trichloroacetic acid are recommended for multiple lesions, similar to the treatment of eccrine hidrocystomas.</p>
      </sec>
      <sec id="article-17775.s16">
        <title>Review Questions</title>
        <list list-type="bullet">
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=17775&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=17775">Access free multiple choice questions on this topic.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://mdsearchlight.com/health/apocrine-hidrocystoma/?utm_source=pubmedlink&#x00026;utm_campaign=MDS&#x00026;utm_content=17775">Click here for a simplified version.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/articlelibrary/commentarticle/17775/?utm_source=pubmed&#x00026;utm_campaign=comments&#x00026;utm_content=17775">Comment on this article.</ext-link>
</p>
          </list-item>
        </list>
      </sec>
    </body>
    <back>
      <floats-group id="article-17775.s17">
        <fig id="article-17775.image.f1" position="float" orientation="portrait">
          <caption>
            <p>Apocrine Hidrocystoma. The lesion appears as an intradermal, moderately firm, dome-shaped, translucent cystic nodule with a grayish or purple hue, as seen on the patient's left cheek. Contributed by T Badri, MD</p>
          </caption>
          <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="Apocrine__hidrocystoma" position="float" orientation="portrait"/>
        </fig>
      </floats-group>
      <ref-list id="article-17775.s18">
        <title>References</title>
        <ref id="article-17775.r1">
          <label>1</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Belaldavar</surname>
                <given-names>BP</given-names>
              </name>
              <name>
                <surname>Suranagi</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Kalakuntla</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Raj</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Tiwari</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>Apocrine Hidrocystoma: A Rare Case Report.</article-title>
            <source>Indian J Otolaryngol Head Neck Surg</source>
            <year>2019</year>
            <month>Oct</month>
            <volume>71</volume>
            <issue>Suppl 1</issue>
            <fpage>59</fpage>
            <page-range>59-61</page-range>
            <pub-id pub-id-type="pmid">31741931</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17775.r2">
          <label>2</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Birkenbeuel</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Goshtasbi</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Mahboubi</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Djalilian</surname>
                <given-names>HR</given-names>
              </name>
            </person-group>
            <article-title>Recurrent apocrine hidrocystoma of the external auditory canal.</article-title>
            <source>Am J Otolaryngol</source>
            <year>2019</year>
            <season>Mar-Apr</season>
            <volume>40</volume>
            <issue>2</issue>
            <fpage>312</fpage>
            <page-range>312-313</page-range>
            <pub-id pub-id-type="pmid">30717993</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17775.r3">
          <label>3</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Sarabi</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Khachemoune</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>Hidrocystomas--a brief review.</article-title>
            <source>MedGenMed</source>
            <year>2006</year>
            <month>Sep</month>
            <day>06</day>
            <volume>8</volume>
            <issue>3</issue>
            <fpage>57</fpage>
            <pub-id pub-id-type="pmid">17406184</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17775.r4">
          <label>4</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Cape</surname>
                <given-names>HT</given-names>
              </name>
              <name>
                <surname>Mukit</surname>
                <given-names>FA</given-names>
              </name>
              <name>
                <surname>Mukit</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Anelo</surname>
                <given-names>OM</given-names>
              </name>
              <name>
                <surname>Krassilnik</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Dadireddy</surname>
                <given-names>K</given-names>
              </name>
            </person-group>
            <article-title>Apocrine Hidrocystoma of the Upper Eyelid.</article-title>
            <source>Eplasty</source>
            <year>2022</year>
            <volume>22</volume>
            <fpage>ic13</fpage>
            <pub-id pub-id-type="pmid">36072057</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17775.r5">
          <label>5</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Igarashi</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Kase</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Suimon</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Takakuwa</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Ishida</surname>
                <given-names>S</given-names>
              </name>
            </person-group>
            <article-title>Conjunctival cyst with apocrine hidrocystoma-like features: a case report.</article-title>
            <source>Int J Ophthalmol</source>
            <year>2023</year>
            <volume>16</volume>
            <issue>3</issue>
            <fpage>465</fpage>
            <page-range>465-467</page-range>
            <pub-id pub-id-type="pmid">36935784</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17775.r6">
          <label>6</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Connolly</surname>
                <given-names>DM</given-names>
              </name>
              <name>
                <surname>McGeehin</surname>
                <given-names>EL</given-names>
              </name>
              <name>
                <surname>Lee</surname>
                <given-names>JB</given-names>
              </name>
            </person-group>
            <article-title>Apocrine cystadenoma: A long-standing apocrine hidrocystoma with an adenomatous proliferation.</article-title>
            <source>J Cutan Pathol</source>
            <year>2024</year>
            <month>Mar</month>
            <volume>51</volume>
            <issue>3</issue>
            <fpage>251</fpage>
            <page-range>251-257</page-range>
            <pub-id pub-id-type="pmid">38084825</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17775.r7">
          <label>7</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>May</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Chang</surname>
                <given-names>O</given-names>
              </name>
              <name>
                <surname>Compton</surname>
                <given-names>N</given-names>
              </name>
            </person-group>
            <article-title>A giant apocrine hidrocystoma of the trunk.</article-title>
            <source>Dermatol Online J</source>
            <year>2017</year>
            <month>Sep</month>
            <day>15</day>
            <volume>23</volume>
            <issue>9</issue>
            <pub-id pub-id-type="pmid">29469730</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17775.r8">
          <label>8</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Ma</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Jakobiec</surname>
                <given-names>FA</given-names>
              </name>
              <name>
                <surname>Wolkow</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Dryja</surname>
                <given-names>TP</given-names>
              </name>
              <name>
                <surname>Borodic</surname>
                <given-names>GE</given-names>
              </name>
            </person-group>
            <article-title>Multiple Eyelid Cysts (Apocrine and Eccrine Hidrocystomas, Trichilemmal Cyst, and Hybrid Cyst) in a Patient With a Prolactinoma.</article-title>
            <source>Ophthalmic Plast Reconstr Surg</source>
            <year>2018</year>
            <season>May/Jun</season>
            <volume>34</volume>
            <issue>3</issue>
            <fpage>e83</fpage>
            <page-range>e83-e85</page-range>
            <pub-id pub-id-type="pmid">29351118</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17775.r9">
          <label>9</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Chen</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>James</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Leibovitch</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Selva</surname>
                <given-names>D</given-names>
              </name>
            </person-group>
            <article-title>Primary orbital apocrine hidrocystoma with sebaceous elements.</article-title>
            <source>Clin Exp Ophthalmol</source>
            <year>2018</year>
            <month>Jul</month>
            <volume>46</volume>
            <issue>5</issue>
            <fpage>560</fpage>
            <page-range>560-562</page-range>
            <pub-id pub-id-type="pmid">29205711</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17775.r10">
          <label>10</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Magdaleno-Tapial</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Valenzuela-O&#x000f1;ate</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Mart&#x000ed;nez-Dom&#x000e9;nech</surname>
                <given-names>&#x000c1;</given-names>
              </name>
              <name>
                <surname>Garc&#x000ed;a-Legaz-Mart&#x000ed;nez</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Mart&#x000ed;nez-Aparicio</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Alegre-de Miquel</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>P&#x000e9;rez-Ferriols</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>Apocrine hidrocystoma on the nipple: the first report in this unusual location.</article-title>
            <source>Dermatol Online J</source>
            <year>2019</year>
            <month>Oct</month>
            <day>15</day>
            <volume>25</volume>
            <issue>10</issue>
            <pub-id pub-id-type="pmid">31735014</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17775.r11">
          <label>11</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Nam</surname>
                <given-names>JH</given-names>
              </name>
              <name>
                <surname>Lee</surname>
                <given-names>GY</given-names>
              </name>
              <name>
                <surname>Kim</surname>
                <given-names>WS</given-names>
              </name>
              <name>
                <surname>Kim</surname>
                <given-names>KJ</given-names>
              </name>
            </person-group>
            <article-title>Eccrine hidrocystoma in a child: an atypical presentation.</article-title>
            <source>Ann Dermatol</source>
            <year>2010</year>
            <month>Feb</month>
            <volume>22</volume>
            <issue>1</issue>
            <fpage>69</fpage>
            <page-range>69-72</page-range>
            <pub-id pub-id-type="pmid">20548887</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17775.r12">
          <label>12</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Ludzik</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Lee</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Mengden</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Nguyen</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Pleshakov</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Witkowski</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>Dermoscopy and Reflectance Confocal Microscopy of Apocrine Hidrocystoma.</article-title>
            <source>Dermatol Pract Concept</source>
            <year>2023</year>
            <month>Jan</month>
            <day>01</day>
            <volume>13</volume>
            <issue>1</issue>
            <pub-id pub-id-type="pmid">36892387</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17775.r13">
          <label>13</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Mendoza-Cembranos</surname>
                <given-names>MD</given-names>
              </name>
              <name>
                <surname>Haro</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Requena</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Alegr&#x000ed;a-Landa</surname>
                <given-names>V</given-names>
              </name>
            </person-group>
            <article-title>Digital Apocrine Hidrocystoma: The Exception Confirms the Rule.</article-title>
            <source>Am J Dermatopathol</source>
            <year>2019</year>
            <month>Jan</month>
            <volume>41</volume>
            <issue>1</issue>
            <fpage>79</fpage>
            <page-range>79-80</page-range>
            <pub-id pub-id-type="pmid">29135506</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17775.r14">
          <label>14</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Nitzsche</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Ziemer</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Voth</surname>
                <given-names>H</given-names>
              </name>
            </person-group>
            <article-title>Surgical management of apocrine hidrocystoma on the penile shaft.</article-title>
            <source>Int J Dermatol</source>
            <year>2018</year>
            <month>Jan</month>
            <volume>57</volume>
            <issue>1</issue>
            <fpage>92</fpage>
            <page-range>92-93</page-range>
            <pub-id pub-id-type="pmid">28994105</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17775.r15">
          <label>15</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Johnson</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Gardner</surname>
                <given-names>JM</given-names>
              </name>
              <name>
                <surname>Shalin</surname>
                <given-names>SC</given-names>
              </name>
            </person-group>
            <article-title>Polarizable crystals in apocrine sweat gland tumors: A series of 3 cases.</article-title>
            <source>J Cutan Pathol</source>
            <year>2017</year>
            <month>Aug</month>
            <volume>44</volume>
            <issue>8</issue>
            <fpage>698</fpage>
            <page-range>698-702</page-range>
            <pub-id pub-id-type="pmid">28497640</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17775.r16">
          <label>16</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Poli</surname>
                <given-names>PP</given-names>
              </name>
              <name>
                <surname>Creminelli</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Moramarco</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Del Gobbo</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Ferrante</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Maiorana</surname>
                <given-names>C</given-names>
              </name>
            </person-group>
            <article-title>Diagnostic Workup and Treatment of a Rare Apocrine Hidrocystoma Affecting the Oral Mucosa: A Clinical and Histological Case Report.</article-title>
            <source>Case Rep Dent</source>
            <year>2017</year>
            <volume>2017</volume>
            <fpage>9382812</fpage>
            <pub-id pub-id-type="pmid">28781903</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17775.r17">
          <label>17</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Osaki</surname>
                <given-names>TH</given-names>
              </name>
              <name>
                <surname>Osaki</surname>
                <given-names>MH</given-names>
              </name>
              <name>
                <surname>Osaki</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Viana</surname>
                <given-names>GA</given-names>
              </name>
            </person-group>
            <article-title>A Minimally Invasive Approach for Apocrine Hidrocystomas of the Eyelid.</article-title>
            <source>Dermatol Surg</source>
            <year>2016</year>
            <month>Jan</month>
            <volume>42</volume>
            <issue>1</issue>
            <fpage>134</fpage>
            <page-range>134-6</page-range>
            <pub-id pub-id-type="pmid">26716715</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17775.r18">
          <label>18</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Anandasabapathy</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Soldano</surname>
                <given-names>AC</given-names>
              </name>
            </person-group>
            <article-title>Multiple apocrine hidrocystomas.</article-title>
            <source>Dermatol Online J</source>
            <year>2008</year>
            <month>May</month>
            <day>15</day>
            <volume>14</volume>
            <issue>5</issue>
            <fpage>12</fpage>
            <pub-id pub-id-type="pmid">18627748</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17775.r19">
          <label>19</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Pandher</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Cerci</surname>
                <given-names>FB</given-names>
              </name>
              <name>
                <surname>Tolkachjov</surname>
                <given-names>SN</given-names>
              </name>
            </person-group>
            <article-title>Apocrine hidrocystoma: a slowly growing postauricular translucent nodule.</article-title>
            <source>Dermatol Online J</source>
            <year>2021</year>
            <month>Jan</month>
            <day>15</day>
            <volume>27</volume>
            <issue>1</issue>
            <pub-id pub-id-type="pmid">33560798</pub-id>
          </element-citation>
        </ref>
      </ref-list>
    </back>
  </book-part>
</book-part-wrapper>
